GlassScriptPhysician profile
John Michael Savko
NPI 1194861575
$7,325.79
in general payments reported to CMS, 2019-2025
8 companies · $1,612 in 2025
The $1,612 reported for 2025 was more than what 97% of General Practice (Dentist) providers received nationally (typical 2025 total: $74.60).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $47.62 · 2021: $40.07 · 2022: $1,547 · 2023: $2,598 · 2024: $1,481 · 2025: $1,612.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $2,602 · Food and Beverage: $2,400 · Entertainment: $565 · Gift: $124.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $2,602.03 |
| Food and Beverage | $2,400.42 |
| Entertainment | $564.53 |
| Gift | $123.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dentsply Sirona INC | $3,857.93 | 2022-2025 | Implant Dentistry, Astra Tech Implant System, Atlantis |
| Patterson Companies, INC. | $3,000.00 | 2022-2025 | |
| Kuraray America INC. | $144.68 | 2024 | |
| Straumann USA LLC | $124.55 | 2019-2025 | |
| Ultradent Products INC | $123.98 | 2024 | Opalescence |
| 3m Company | $40.07 | 2021 | |
| Solventum Corporation | $20.16 | 2024 | 3m Espe Filtek Supreme Ultra Universal Restorative |
| Envista Holdings Corporation | $14.42 | 2025 | Maxcem Elite |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Savko listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.